logo

Canadian News

Share SHARE

The Brazilian government will request that the World Trade Organization's (WTO) Dispute Settlement Body to set up a panel to discuss the case against Canada related to subsidies given by the North American country to the aviation sector, benefiting Bombardier's C-Series program, which competes with Brazil's...

Canadian stocks tumbled Friday amid indications a rate hike from the Bank of Canada is in the cards. Headline inflation rate rose to 1.2 percent from June's 20-month low of 1.0 per cent, matching analysts' expectations, and core inflation stripping out energy prices were also higher, Statistics Canada...

The Canadian stock market got off to a weak start Friday, but has since come off its early lows. The majority of the Canadian sectors are trading in the red this morning, with information technology and industrial names under the heaviest pressure. Meanwhile, gold stocks are rising this morning as...

The Canadian dollar climbed against its major rivals in the European session on Friday, after a data showed that the nation's inflation improved more than forecast in July. Data from Statistics Canada showed that Canadian inflation rose 0.2 percent on a seasonally adjusted monthly basis in July. This...

Following the release of Canada consumer prices for July at 8:30 am ET Friday, the loonie advanced against its major rivals. The loonie was trading at 1.4835 against the euro, 86.33 against the yen, 1.0002 against the aussie and 1.2627 against the greenback around 8:32 am ET.

Statistics Canada will release Canada consumer prices for July at 8:30 am ET Friday. Inflation is expected to be flat on month, following a 0.1 percent decline in June. Ahead of the data, the loonie traded mixed against its major rivals. While the loonie held steady against the euro, it dropped against...

Early signals are positive for Canadian stocks Friday morning, as higher commodity prices could help miners rally. The TSX Composite Index is at its lowest of the year, having drifted down over the past two months. WTI light sweet crude oil was up 20 cents at $47.21 a barrel. Oil exports from Iraq's...

anipharma-081817.jpg In today's Spotlight column, the company we are featuring is ANI Pharmaceuticals Inc. (ANIP).

Calpine Corp. (CPN) announced a definitive agreement under which Energy Capital Partners along with a consortium of investors led by Access Industries and Canada Pension Plan Investment Board will acquire Calpine for $15.25 per share in cash, or $5.6 billion. The transaction was unanimously approved...

The U.S. dollar dropped against its major opponents in early European deals on Friday, as rumors over the possible departure of National Economic Council Director Gary Cohn triggered doubts about U.S. President Donald Trump's ability to push through his economic agenda. After Trump disbanded two...

The U.S. dollar dropped against its most major opponents in early European deals on Friday. The greenback fell to a weekly low of 108.99 against the yen, after having advanced to 109.55 at 9:00 pm ET. The greenback slipped to 1.2899 against the pound and 1.1758 against the euro, off its early...

Shanta Gold (SHG.L), an East Africa-focused gold producer, reported Friday that its first-half loss after taxation was $2.1 million, narrower than last year's loss of $4.7 million. Revenue declined to $52.7 million from $55.7 million last year. EBITDA was $21.5 million, compared to $33.3 million...

The Canadian dollar weakened against most major currencies in tha Asian session on Friday. The Canadian dollar fell to a 2-day low of 1.2691 against the U.S. dollar and a 4-day low of 86.13 against the yen, from yesterday's closing quotes of 1.2679 and 86.38, respectively. Against the euro, the...

The Australian dollar weakened against other major currencies in the Asian session on Friday. The Australian dollar fell to a 1-week low of 86.03 against the yen and a 2-day low of 1.4881 against the euro, from yesterday's closing quotes of 86.37 and 1.4867, respectively. Against the U.S., the...

Pharma-081817.jpg Today's Daily Dose brings you news about expanded FDA approval of AstraZeneca's ovarian cancer drug Lynparza; positive results from Endologix's LEOPARD trial; Fluidigm's licensing agreement with Baylor Genetics; Humana and Amgen's partnership to improve health outcomes and efficiency and Pfizer's Besponsa getting thumbs up from the U.S. regulatory agency.

Follow RTT